# Degarelix Neo-Adjuvant Radical Prostatectomy Trial

> **NCT01674270** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 35 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Degarelix
- **DRUG:** Casodex
- **DRUG:** LHRH Agonist

## Key facts

- **NCT ID:** NCT01674270
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-12
- **Final completion:** 2015-11
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2015-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01674270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01674270, "Degarelix Neo-Adjuvant Radical Prostatectomy Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01674270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*